About Amclin Life Sciences Private Limited
Data last updated:
Amclin Life Sciences Private Limited was a private limited company based in Pune, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 May 2015.
The company was registered with the Registrar of Companies (ROC), Pune, under CIN U74900PN2015PTC155009. The company has 2 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹50 Lakh and a paid-up capital of ₹30 Lakh. It was led by directors including Amol Ashok Lawande and Ashok Trimbak Lawande.
Its last annual general meeting (AGM) was held on 28 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Pune, Maharashtra.
As per the financials filed for FY 2018, the company reported a revenue of ₹43.94 Lakh, a decline of 45% compared to the previous year. For the same year it recorded a net loss of ₹39.08 Lakh (net margin -88.9%) and EBITDA of -₹37.63 Lakh (EBITDA margin -85.6%).
The company was associated with 1 brand: Amclin Life Sciences. Court records list 3 cases involving the company, including 3 filed against it; 1 case is pending. The company has 1 deal on record (1 rights issue); the latest was in November 2017.
The last known website on record is amclin.com.
Company details
Contact details
Amclin Life Sciences Private Limited's registered office is in Pune, Maharashtra. Its website is amclin.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressShop No 9 And 10 Parmar Square Co Op Hsg Soc Ltd S.No 6 Hissa No.1 Near Zensar IT Tower, Kharadi, Pune, Maharashtra, India – 411014
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Amclin Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Amclin Life Sciences operates one associated brand: Amclin Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides full-service CRO and SMO solutions for clinical research and site management. | amclin.com |
Business activity
The main business activity of Amclin Life Sciences is information and communication. In detail, this covers other information & communication service activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J8 | Other information & communication service activities |
To see the full business activity and turnover split of Amclin Life Sciences Private Limited, buy the company report.
Financials of Amclin Life Sciences Private Limited
FY 2018 filings availableAmclin Life Sciences Private Limited reported revenue of ₹43.94 Lakh (down 45% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 45% in the latest year. EBITDA fell 395% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹43.94 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹37.63 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹39.08 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -85.6% | ||
| Net Profit Margin | -88.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Amclin Life Sciences Private Limited, buy the company report.
Board of directors of Amclin Life Sciences Private Limited
Amclin Life Sciences has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amol Ashok Lawande | Director | 14 May 2015 | 11 Years 5 Months | As last reported |
| Ashok Trimbak Lawande | Director | 14 May 2015 | 11 Years 5 Months | As last reported |
| Pratibha Amol Lawande | Director | 14 May 2015 | 11 Years 5 Months | As last reported |
Auditor
Amclin Life Sciences Private Limited is audited by K R P R & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K R P R & ASSOCIATES | FY 2018 | 133672W |
Shareholding
The shareholding of Amclin Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Amclin Life Sciences Private Limited, buy the company report.
Deals & funding
Amclin Life Sciences Private Limited has 1 deal on record (1 rights issue); the latest was in November 2017.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2017 | Rights issue | ₹29 Lakh | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Amclin Life Sciences Private Limited has 3 court cases on record: 3 filed against it. 1 case is pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Execution petition | Filed against the company by Tata Capital Financial Services Limited | Pending |
| District court, Pune, Maharashtra | Execution petition | Filed against the company by Tata Capital Financial Services Limited | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Tata Capital Financial Service Ltd | Disposed |
To see the full case history of Amclin Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amclin Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Amclin Life Sciences has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Amclin Life Sciences Private Limited, buy the company report.
Recent activity
Amclin Life Sciences Private Limited has 3 board changes on record since 2015: 3 appointments. The latest: Amol Ashok Lawande was appointed as Director on 14 May 2015.
Frequently asked questions
Amclin Life Sciences has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Amclin Life Sciences was a private limited company based in Pune, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 14 May 2015 and is registered under CIN U74900PN2015PTC155009. The company has been struck off by the Registrar of Companies and is no longer operational.
Amclin Life Sciences had 3 directors:
- Amol Ashok Lawande - Director
- Ashok Trimbak Lawande - Director
- Pratibha Amol Lawande - Director
The CIN (Corporate Identification Number) of Amclin Life Sciences is U74900PN2015PTC155009. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Amclin Life Sciences is at Shop No 9 And 10 Parmar Square Co Op Hsg Soc Ltd S.No 6 Hissa No.1 Near Zensar IT Tower, Kharadi, Pune, Maharashtra, India – 411014.
Amclin Life Sciences was incorporated on 14 May 2015. It is registered with the Registrar of Companies, Pune.
Amclin Life Sciences can be reached through the website amclin.com. Its registered office is in Pune, Maharashtra, India.
The latest financial statements of Amclin Life Sciences on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 28 September 2018. Year-wise statements from FY 2016 are in the company report.
No. Amclin Life Sciences has 2 GST registrations on record and all of them are cancelled or inactive.
Amclin Life Sciences operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.